MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2023 International Congress

    Validation and psychometric properties of the Thai version of the hemifacial spasm grading questionnaire (HFS score) for physician-assessed clinical involvement and patient-reported health-related quality of life: a prospective observational study

    ���N. Likhitwitayawuid, Y. Pitakpatapee, W. Saengphatarachai, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: The primary aim was translation to thai and cognitive debriefing of the thai version of the hfs score in patients with hfs. The secondary…
  • 2022 International Congress

    Safety of incobotulinumtoxinA in pediatrics: A pooled analysis

    F. Heinen, M. Banach, E. Dabrowski, D. Gaebler-Spira, H. Chambers, S. Schroeder, T. Geister, M. Althaus, A. Hanschmann, S. Berweck (Munich, Germany)

    Objective: To present analyses of pooled data on the safety of incobotulinumtoxinA (INCO) in pediatrics Background: BotulinumtoxinA (BoNT-A) is used to treat several conditions affecting…
  • 2022 International Congress

    Botulinum Toxin A in the Management of peripheral mononeuropathy: post herpetic neuralgia and trigeminal neuralgia

    F. Ortega (guatemala, Guatemala)

    Objective: The purpose of this study is determinate the efficacy and safety of botulin toxin A in the treatment of refractory post herpetic neuralgia and…
  • 2022 International Congress

    Therapeutic approach to botulinum injections for hemifacial spasm, post facial paralysis synkinesis and blepharospasm

    G. Yahalom, A. Janah, R. Eichel (Jerusalem, Israel)

    Objective: To show our therapeutic outcome of botulinum injection to the facial muscles and thereby to find the best therapeutic concept which should be embraced.…
  • 2022 International Congress

    Botulinum toxin injections are an effective treatment for patients with essential head tremor.

    A. Marques, I. Rieu, B. Pereira, G. Castelnovo, F. Fluchère, C. Laurencin, B. Degos, A. Poujois, A. Kreisler, S. Sangla, M. Tir, I. Benatru, G. Blanchet-Fourcade, D. Guehl, D. Gayraud, L. Tatu, C. Tranchant, D. Amarantini, M. Simonetta, F. Durif (Clermont-Ferrand, France)

    Objective: To assess the safety and efficacy of Botulinum toxin (Btx) injections in essential head tremor (HT) in a multicenter, randomized, double blind, parallel-group, placebo-controlled…
  • 2022 International Congress

    IncobotulinumtoxinA to treat sialorrhea in Parkinson’s disease: a real-life study

    B. Bergmans, N. Winter, V. Schotte, N. Sys, E. van Massenhove, H. Couckuyt, M. van Zandijcke (Bruges & Ghent, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea (10 injection cycles (IC) into…
  • 2022 International Congress

    Botulinum neurotoxin simulation workshop: Impact on resident satisfaction and knowledge

    C. Selvadurai, E. Cournean, N. Prakash, B. Rodrigues (Farmington, USA)

    Objective: To assess resident satisfaction and knowledge after a hands-on Botulinum toxin (BoNT) simulation workshop (SW). Background: Despite having an application for BoNT in almost…
  • 2022 International Congress

    Limb myorhythmia treated with chemodenervation: A case report

    N. Saez Calveras, M. Bryarly, M. Salinas (Dallas, USA)

    Objective: To describe the case of a patient with limb myorhythmia successfully treated with bolutinum toxin injections. Background: Myorhythmia is a rare condition characterized by…
  • 2022 International Congress

    Hypersensitive reaction to botulinum toxin type A following Covid19 mRNA vaccination

    VL. Livneh, L. Barsky, H. Shabtai, A. Ezra, T. Gurevich (Tel Aviv, Israel)

    Objective: two cases of hypersensitivity reactions to botulinum toxin type A (BTA) following mRNA based COVID-19 vaccine Background: Botulinum toxin type A is  widely used…
  • 2022 International Congress

    Lack of immunogenicity of incobotulinumtoxinA in pediatrics: A pooled analysis

    F. Heinen, M. Banach, E. Dabrowski, D. Gaebler-Spira, H. Chambers, S. Schroeder, T. Geister, M. Althaus, A. Hanschmann, S. Berweck (Munich, Germany)

    Objective: To present pooled data analyses of the immunogenicity of incobotulinumtoxinA (INCO) in pediatrics. Background: BotulinumtoxinA (BoNT-A) is used to treat several chronic pediatric conditions,…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 12
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • #25179 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley